Kodu・Aktsiate loetelu・Agilent Technologies Inc

Agilent Technologies Inc

Suletud

SektorTervishoid

139.31 -0.27

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

138.06

Max

140.31

Põhinäitajad
By Trading Economics
Sissetulek	34M 339M
Müük	37M 1.8B
P/E Sektori keskmine	27.745 64.641
Aktsiakasum	1.49
Dividenditootlus	0.73
Kasumimarginaal	18.474
Töötajad	18,000
EBITDA	44M 500M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+12.11% upside

Dividendid
By Acuity
Dividenditootlus Sektori keskmine	0.73% 2.31%
Järgmine tulemuste avaldamine	26. aug 2026
Järgmine dividendimakse kuupäev	21. okt 2026
Järgmine aktsia dividendi kuupäev (ex-date)	29. sept 2026

Turustatistika
By TradingEconomics
Turukapital	6.5B 39B
Eelmine avamishind	139.58
Eelmine sulgemishind	139.31

Uudiste sentiment

By Acuity

16%

84%

22 / 340 Pingereas Healthcare

Agilent Technologies Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

31. juuli 2026, 20:03 UTC

Agilent Technologies Inc shares are lower today, impacted by a decline in the Life Sciences Tools & Services sub-sector. No specific news was identified.

30. juuli 2026, 19:58 UTC

Agilent Technologies Inc. is trading lower, continuing a decline since Wednesday's close. The Nasdaq 100 Index has increased, contrasting with Agilent's performance.

29. juuli 2026, 19:56 UTC

Agilent Technologies Inc shares are lower amid broader market pressures from rising crude oil prices and inflation concerns affecting equities.

28. juuli 2026, 23:41 UTC

Agilent Technologies shares declined in after-market trading, reflecting broader pressures in technology due to concerns over AI spending and competition from Chinese chipmakers.

27. juuli 2026, 22:36 UTC

Agilent Technologies Inc shares are higher in after-market trading, supported by strong performance. The stock remains above its 20-day moving average.

24. juuli 2026, 19:07 UTC

News

Agilent Technologies Inc shares are trading lower amid concerns over sales trends and underperformance compared to healthcare peers. The stock remains above its 20-day moving average.

23. juuli 2026, 20:03 UTC

Correlated Moves

News

Agilent Technologies received EU certification for its PD-L1 IHC 22C3 diagnostic, boosting shares during Thursday's session. This marks the eighth CE-marked indication in the EU.

22. juuli 2026, 21:46 UTC

Correlated Moves

Agilent Technologies Inc. is higher in after-market trading, supported by a rise in Thermo Fisher Scientific Inc. and overall life sciences sector performance.

21. juuli 2026, 20:02 UTC

News

Agilent Technologies has received FDA approval for its PD-L1 IHC 28-8 assay, boosting shares as analysts express positive sentiment on its future prospects.

20. juuli 2026, 19:22 UTC

News

Agilent Technologies Inc. shares are lower amid broader market declines and rising Treasury yields, despite a "Moderate Buy" consensus from analysts.

Võrdlus sarnastega

Hinnamuutus

Agilent Technologies Inc Prognoos

Hinnasiht

By TipRanks

12.11% tõus

12 kuu keskmine prognoos

Keskmine 155.13 USD 12.11%

Kõrge 180 USD

Madal 135 USD

Põhineb 16 Wall Streeti analüütiku instrumendi Agilent Technologies Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

16 ratings

Osta

Hoia

Müü

Põhineb 16 analüütiku instrumendi Agilent Technologies Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

22 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.